Mumbai . Park Medi World Limited (the “Company”) will open its bids/offers in respect of its initial public offer of equity shares on Wednesday, December 10, 2025. The fresh issue of up to Rs 7,700 million (₹770 crore) and a fresh issue of up to Rs 1,500 million (₹150 crore) by Dr. Ajit Gupta (the “Promoter Selling Shareholder”) for an aggregate offer size of up to Rs 9,200 million (₹920 crore). Sales Offer Size (“Total Offer Size”).

The anchor investor bid date will be Tuesday, December 9, 2025. Bids/proposals will open for subscription on Wednesday, December 10, 2025 and close on Friday, December 12, 2025.

The price band of the offer has been set at Rs 154 to Rs 162 per equity share. Bids can be placed for a minimum of 92 equity shares and in multiples of 92 equity shares thereafter.

The Company proposes to utilize the net proceeds from the fresh issue of equity shares for: (i) full or partial repayment/prepayment of outstanding loans taken by the Company and its subsidiaries; (ii) funding of capital expenditure for the development of the new hospital by the subsidiary company, Park Medicity (NCR); (iii) financing of capital expenditure for medical device purchases by our Company and our subsidiaries, Blue Heavens and Ratnagiri; and (iv) the remaining amount for undisclosed inorganic acquisitions and general corporate purposes (“Purpose of the Issue”).
The offer for sale comprises a number of equity shares of face value of Rs 2 each, up to Rs 1,500.00 million (₹150 crore) by the promoter selling shareholder.
Nuvama Wealth Management Limited, CLSA India Private Limited, Dam Capital Advisors Limited and Intensive Fiscal Services Private Limited are the book running lead managers (BRLMs) for the offer.

The Equity Shares are being offered through the Company’s Red Herring Prospectus (RHP) dated December 4, 2025, filed with the Registrar of Companies, Delhi and Haryana, New Delhi (“ROC”) and it is proposed to be listed on the Bombay Stock Exchange Limited (“BSE”) and the National Stock Exchange of India Limited (“NSE”).